Rho kinase-dependent activation of SOX9 in chondrocytes

Arthritis and Rheumatism

Volumn 62, Issue 1, 2010, Pages 191-200

  Haudenschild, Dominik R ^a,b,c   Chen, Jianfen ^a   Pang, Nina ^b   Lotz, Martin K ^a   D'Lima, Darryl D ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; LIM KINASE; LUCIFERASE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING SITE; CARTILAGE CELL; CARTILAGE MATRIX; CHONDROSARCOMA; COMPRESSION; CONSENSUS; CONTROLLED STUDY; DOSE RESPONSE; ENHANCER REGION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; CARTILAGE; CELL LINE, TUMOR; CHONDROCYTES; CONSENSUS SEQUENCE; ENZYME ACTIVATION; HUMANS; LIM KINASES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; RHO-ASSOCIATED KINASES; SOX9 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 74849088249     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.25051     Document Type: Article

References (50)

1. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006;97:33-44.
2. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332-6.
3. Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B. Control of cell fate and differentiation by Sry-related highmobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 2007;39:2195-214.
4. Goodwin GH, Sanders C, Johns EW. A new group of chromatinassociated proteins with a high content of acidic and basic amino acids. Eur J Biochem 1973;38:14-9.
5. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet 1999;22:85-9.
6. Wright E, Hargrave MR, Christiansen J, Cooper L, Kun J, Evans T, et al. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 1995;9:15-20.
7. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997;16:174-8.
8. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro α1(II) collagen gene. Mol Cell Biol 1997;17: 2336-46.
9. Ng LJ, Wheatley S, Muscat GE, Conway-Campbell J, Bowles J, Wright E, et al. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 1997;183:108-21.
10. Zhang P, Jimenez SA, Stokes DG. Regulation of human COL9A1 gene expression: activation of the proximal promoter region by SOX9. J Biol Chem 2003;278:117-23.
11. Bridgewater LC, Lefebvre V, de Crombrugghe B. Chondrocytespecific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 1998;273: 14998-5006.
12. Sekiya I, Tsuji K, Koopman P, Watanabe H, Yamada Y, Shinomiya K, et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilagederived cell line, TC6. J Biol Chem 2000;275:10738-44.
13. Kou I, Ikegawa S. SOX9-dependent and-independent transcriptional regulation of human cartilage link protein. J Biol Chem 2004;279:50942-8.
14. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002;16: 2813-28.
15. Okubo Y, Reddi AH. Thyroxine downregulates Sox9 and promotes chondrocyte hypertrophy. Biochem Biophys Res Commun 2003;306:186-90.
16. Kawakami Y, Rodriguez-Leon J, Belmonte JC. The role of TGFβ and Sox9 during limb chondrogenesis. Curr Opin Cell Biol 2006; 18:723-9.
17. Huang W, Zhou X, Lefebvre V, de Crombrugghe B. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocytespecific enhancer. Mol Cell Biol 2000;20:4149-58.
18. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci U S A 2001;98:160-5.
19. Preiss S, Argentaro A, Clayton A, John A, Jans DA, Ogata T, et al. Compound effects of point mutations causing campomelic dysplasia/ autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activation. J Biol Chem 2001;276:27864-72.
20. Malki S, Nef S, Notarnicola C, Thevenet L, Gasca S, Mejean C, et al. Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. EMBO J 2005;24:1798-809.
21. Chikuda H, Kugimiya F, Hoshi K, Ikeda T, Ogasawara T, Shimoaka T, et al. Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev 2004;18:2418-29.
22. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 1978;15:1313-21.
23. Dessau W, Vertel BM, von der Mark H, von der Mark K. Extracellular matrix formation by chondrocytes in monolayer culture. J Cell Biol 1981;90:78-83.
24. Glowacki J, Trepman E, Folkman J. Cell shape and phenotypic expression in chondrocytes. Proc Soc Exp Biol Med 1983;172:93-8.
25. Woods A, Wang G, Beier F. Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol 2007;213:1-8.
26. Zanetti NC, Solursh M. Induction of chondrogenesis in limb mesenchymal cultures by disruption of the actin cytoskeleton. 1. J Cell Biol 1984;99:115-23.
27. Ridley AJ. Rho family proteins: coordinating cell responses. Trends Cell Biol 2001;11:471-7.
28. Sorokina EM, Chernoff J. Rho-GTPases: new members, new pathways. J Cell Biochem 2005;94:225-31.
29. Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol 2008;20:242-8.
30. Woods A, Wang G, Beier F. RhoA/ROCK signaling regulates Sox9 expression and actin organization during chondrogenesis. J Biol Chem 2005;280:11626-34.
31. Woods A, Beier F. RhoA/ROCK signaling regulates chondrogenesis in a context-dependent manner. J Biol Chem 2006;281: 13134-40.
32. Aigner T, Gebhard PM, Schmid E, Bau B, Harley V, Poschl E. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 2003;22:363-72.
33. Haudenschild DR, Nguyen B, Chen J, D'Lima DD, Lotz MK. Rho kinase-dependent CCL20 induced by dynamic compression of human chondrocytes. Arthritis Rheum 2008;58:2735-42.
34. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M, et al. Sox9 and p300 cooperatively regulate chromatinmediated transcription. J Biol Chem 2005;280:35203-8.
35. Haudenschild DR, D'Lima DD, Lotz MK. Dynamic compression of chondrocytes induces a Rho kinase-dependent reorganization of the actin cytoskeleton. Biorheology 2008;45:219-28.
36. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006;7:R100.
37. Kang JH, Jiang Y, Toita R, Oishi J, Kawamura K, Han A, et al. Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ ROK) substrates by protein kinases A and C. Biochimie 2007;89: 39-47.
38. Croft DR, Olson MF. Conditional regulation of a ROCK-estrogen receptor fusion protein. Methods Enzymol 2006;406:541-53.
39. Schwartz M. Rho signalling at a glance. J Cell Sci 2004;117:5457-8.
40. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-56.
41. Daniels K, Solursh M. Modulation of chondrogenesis by the cytoskeleton and extracellular matrix. J Cell Sci 1991;100(Pt 2):249-54.
42. De Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 2000;19:389-94.
43. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279:509-14.
44. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33(Pt 5):891-5.
45. Moroianu J. Nuclear import and export: transport factors, mechanisms and regulation. Crit Rev Eukaryot Gene Expr 1999;9: 89-106.
46. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36.
47. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 2005;280: 8343-50.
48. Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-β-mediated Smaddependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 2005;280:1024-36.
49. Kawakami Y, Tsuda M, Takahashi S, Taniguchi N, Esteban CR, Zemmyo M, et al. Transcriptional coactivator PGC-1α regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci U S A 2005;102:2414-9.
50. Bhowmick NA, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL. TGF-β-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci U S A 2003;100:15548-53.